Medicare PBM rebate ban could migrate to private sector

Medicare PBM rebate ban could migrate to private sector

Source: 
BioCentury
snippet: 

The Trump administration’s proposed rule barring drug companies from paying rebates to PBMs and drug plans for Part D Medicare could also affect commercial payers, HHS Secretary Alex Azar said Friday.